Kunming Longjin Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Lijuan Fan
Chief executive officer
CN¥368.6k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.1yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
What Kunming Longjin Pharmaceutical Co., Ltd.'s (SZSE:002750) 38% Share Price Gain Is Not Telling You
Aug 14
Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) May Have Run Too Fast Too Soon With Recent 40% Price Plummet
Jun 30Risks Still Elevated At These Prices As Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) Shares Dive 26%
Apr 26We're Not Very Worried About Kunming Longjin Pharmaceutical's (SZSE:002750) Cash Burn Rate
Apr 17Revenues Not Telling The Story For Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) After Shares Rise 29%
Mar 08CEO
Lijuan Fan (38 yo)
1.1yrs
Tenure
CN¥368,600
Compensation
Ms. Lijuan Fan is Non-Independent Director of Kunming Longjin Pharmaceutical Co., Ltd. from January 03, 2024 and also serves as its General Manager.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | 1.1yrs | CN¥368.60k | no data | |
| Deputy GM | 17.1yrs | CN¥322.10k | no data | |
| Independent Director | 4.2yrs | CN¥56.30k | no data | |
| Chairman of the Board | 26.1yrs | CN¥835.10k | 0.59% CN¥ 3.3m | |
| Vice Chairman of the Board of Directors | no data | CN¥638.00k | no data | |
| Non-Employee Supervisor | 17.1yrs | no data | no data | |
| Non-Independent Director | 4.2yrs | CN¥72.00k | no data | |
| Non-Independent Director | 4.2yrs | CN¥172.20k | no data | |
| Chairman of the Supervisory Board | no data | no data | no data | |
| Independent Director | 1.1yrs | CN¥72.00k | no data | |
| Independent Director | 1.1yrs | no data | no data | |
| Independent Director | 1.1yrs | no data | no data |
4.2yrs
Average Tenure
47yo
Average Age
Experienced Board: 002750's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 20:04 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kunming Longjin Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wen Wen Shen | Avic Securities Co., Ltd |